First Clinical Trial Site Initiated in CSL Behring Phase II/III Pivotal Study of Recombinant Fusion Protein Linking Coagulation Factor IX With Recombinant Albumin VIENNA, January 12, 2012, 2012 ...

FRAMINGHAM, Mass.--(BUSINESS WIRE)--LFB SA, through its rEVO Biologics subsidiary, announced today initiation of the global Phase 3 program for LR769, a novel recombinant form of human Factor VIIa, in ...

VARIOUS hypotheses have been put forward in attempts to explain the clotting of milk by rennet. That from the Carlsberg Laboratories 1,2 has probably been the most widely accepted. This theory states ...

Assessment of adrenal function and health-related quality of life in patients with advanced gastric cancer who received first-line chemotherapy. Phase II study with docetaxel (D), cisplatin (C), and ...

Coagulation disorders refer to conditions that affect how the body controls blood clotting. This can mean the body forms too many or too few blood clots. Coagulation disorders are usually due to a ...

During its treatment wastewater must go through several stages, and before sedimentation and filtration it must go through the crucial primary phase of coagulation and flocculation. The direction of ...

LONDON--(BUSINESS WIRE)--The coagulation testing market is expected to grow by USD 991.28 million during 2020-2024, according to Technavio. The report offers a detailed analysis of the impact of COVID ...

Association of tumor PDGFR-α and PDGFR-β expression and survival after resection of hepatocellular carcinoma. Background: PCI-27483 is a selective inhibitor of FVIIa, a serine protease activated by ...